1. Marcum ZA, Vande Griend JP, Linnebur SA. FDA drug safety communications: a narrative review and clinical considerations for older adults. Am J Geriatr Pharmacother. 2012;10(4):264–71.
2. US FDA. Guidance drug safety information: FDA’s communication to the public. Secondary guidance drug safety information: FDA’s communication to the public.
http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM295217.pdf
. Accessed 17 Feb 2017.
3. US FDA. FDA’s safe use initiative: collaborating to reduce preventable harm from medications. Secondary FDA’s safe use initiative: collaborating to reduce preventable harm from medications.
http://www.fda.gov/downloads/Drugs/DrugSafety/UCM188961.pdf
. Accessed 17 Feb 2017.
4. US FDA. Drug safety and availability: secondary food and drug administration. 2014.
http://www.fda.gov/Drugs/DrugSafety/default.htm
. Accessed 17 Feb 2017.
5. Drugs@FDA. Glossary of terms.
http://www.fda.gov/Drugs/InformationOnDrugs/ucm079436.htm#L
. Accessed 22 Aug 2016.